clodronic acid has been researched along with Mandibular Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barthelemy, I; Biau, J; Delbet, C; Depeyre, A; Dissard, A; Gilain, L; Guillemin, F; Martin, F; Mirafzal, S; Mom, T; P Dang, N; Pereira, B; Puechmaille, M; Saroul, N | 1 |
| Biau, J; Clavère, P; Dutheil, F; Guillemin, F; Lapeyre, M; Pham-Dang, N; Saroul, N | 1 |
| Balibrea-Del-Castillo, JM; Bescós-Atín, C; Estrugo-Devesa, A; López-López, J; Martos-Fernández, M; Saez-Barba, M | 1 |
| Dhanda, J; Rennie, L; Shaw, R | 1 |
| Bulsara, MK; Bulsara, VM; Lewis, E | 1 |
| Babin, E; Blanchard, D; Delanian, S; Louis, MY; Robard, L | 1 |
| Costa, DA; Costa, TP; Guerreiro, FG; Joaquim, N; Moreira, AR; Netto, EC; Pinho, AC; Pratas, AC; Sargento, IG; Silva, IP; Ventura, I; Winckler, P | 1 |
| Capodiferro, S; Favia, G; Iezzi, G; Piattelli, A; Sportelli, P | 1 |
| Chatel, C; Delanian, S; Depondt, J; Lefaix, JL; Porcher, R | 1 |
| Carrassi, A; Lodi, G; Sardella, A; Tarozzi, M | 1 |
| Ucok, C | 1 |
| Delanian, S; Depondt, J; Lefaix, JL | 1 |
| Bagis, B; Durmus, A; Saracoglu Tekin, U; Senel, FC | 1 |
| Márton, I; Redl, P; Udvardy, E | 1 |
| Kalso, E; Lindqvist, C; Lindströrm, BM; Montonen, M; Pylkkären, L | 1 |
| Petrovic, AG; Stutzmann, JJ | 1 |
4 review(s) available for clodronic acid and Mandibular Diseases
| Article | Year |
|---|---|
[Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].
Topics: Bone Density Conservation Agents; Clodronic Acid; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Radiotherapy Dosage; Risk Factors; Tocopherols | 2021 |
Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review.
Topics: Clodronic Acid; Drug Combinations; Head and Neck Neoplasms; Humans; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Tocopherols | 2018 |
New perspectives on the conservative management of osteoradionecrosis of the mandible: A literature review.
Topics: Antioxidants; Bone Density Conservation Agents; Clodronic Acid; Conservative Treatment; Drug Therapy, Combination; Humans; Hyperbaric Oxygenation; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Tocopherols | 2016 |
[Osteonecrosis of the jaw developing during bisphosphonate treatment].
Topics: Alendronate; Anti-Infective Agents; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Mandible; Mandibular Diseases; Oral Hygiene; Oral Surgical Procedures; Osteonecrosis; Patient Care Team; Referral and Consultation; Zoledronic Acid | 2008 |
4 trial(s) available for clodronic acid and Mandibular Diseases
| Article | Year |
|---|---|
Protocol for prospective randomised assessor-blinded pilot study comparing hyperbaric oxygen therapy with PENtoxifylline+TOcopherol± CLOdronate for the management of early osteoradionecrosis of the mandible.
Topics: Adult; Bone Density Conservation Agents; Clinical Protocols; Clodronic Acid; Drug Combinations; Female; Humans; Hyperbaric Oxygenation; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Pilot Projects; Prospective Studies; Tocopherols | 2019 |
Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Ciprofloxacin; Clodronic Acid; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Prednisone; Prognosis; Tocopherols | 2011 |
Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial.
Topics: Adult; Aged; Antimetabolites; Antioxidants; Clodronic Acid; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Radiation-Protective Agents; Radiography; Radiotherapy; Tocopherols; Wound Healing | 2005 |
Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Analysis of Variance; Chronic Disease; Clodronic Acid; Double-Blind Method; Facial Pain; Female; Humans; Injections, Intravenous; Male; Mandibular Diseases; Middle Aged; Osteomyelitis; Pain Measurement; Statistics, Nonparametric; Treatment Outcome | 2001 |
8 other study(ies) available for clodronic acid and Mandibular Diseases
| Article | Year |
|---|---|
Efficacy of pentoxifylline-tocopherol-clodronate in mandibular osteoradionecrosis.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Clodronic Acid; Drug Combinations; Female; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Prospective Studies; Tocopherols; Treatment Outcome | 2020 |
Current trends in the medical management of osteoradionecrosis using triple therapy.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Agents; Chlorhexidine; Clodronic Acid; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Mandibular Diseases; Mouthwashes; Osteoradionecrosis; Pentoxifylline; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiation-Protective Agents; Severity of Illness Index; Tocopherols | 2018 |
Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Clodronic Acid; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Middle Aged; Oral Ulcer; Osteoradionecrosis; Pentoxifylline; Radiography, Panoramic; Retrospective Studies; Tocopherols; Wound Healing | 2014 |
Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report.
Topics: Aged; Bone Density Conservation Agents; Clodronic Acid; Dental Implants; Female; Humans; Mandibular Diseases; Osseointegration; Osteonecrosis; Treatment Failure | 2011 |
Bisphosphonate-related osteonecrosis of the jaws associated with photodynamic therapy.
Topics: Aged; Bone Density Conservation Agents; Carcinoma, Verrucous; Clodronic Acid; Female; Humans; Leukoplakia, Oral; Mandibular Diseases; Mandibular Neoplasms; Mesoporphyrins; Neoplasm Recurrence, Local; Osteonecrosis; Osteoporosis; Photochemotherapy; Photosensitizing Agents | 2011 |
Using of disodium clodronate on DSO patients.
Topics: Analgesics, Non-Narcotic; Clodronic Acid; Facial Pain; Humans; Mandibular Diseases; Osteomyelitis | 2003 |
Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case.
Topics: Actinomycosis; Aged; Bone Density Conservation Agents; Clodronic Acid; Female; Humans; Mandibular Diseases; Multiple Myeloma; Osteomyelitis; Osteonecrosis; Tooth Extraction | 2007 |
Diphosphonates for otospongiosis.
Topics: Adult; Bone Development; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Male; Mandible; Mandibular Diseases; Middle Aged; Osteitis Deformans; Otosclerosis; Pamidronate | 1985 |